Latest Regulatory News

Syntara Limited has received FDA guidance recommending a Phase 2 controlled trial for its lead drug amsulostat in myelofibrosis, setting the stage for a pivotal Phase 3 study. The company is poised to refine its clinical strategy while advancing a diverse pipeline with key data milestones ahead.

Dalaroo Metals has successfully completed a placement raising $877,500 through the issue of 35.1 million shares and 11.7 million free attaching options, bolstering its capital position within existing regulatory limits.

Zeotech Limited has secured a binding offtake term sheet with MSI, granting exclusive rights to supply and market its kaolin products across key Asian markets, underpinning its Toondoon Kaolin Project development.

Cyclone Metals Limited has completed a comprehensive Scoping Study for its Iron Bear magnetite project in Canada, revealing strong economic potential and a strategic funding partnership with Vale S.A. The study outlines multiple production scenarios and highlights the project's alignment with low-carbon steelmaking trends.

Santana Minerals has raised A$63 million through a fully underwritten placement and a Share Purchase Plan to fast-track development of its Bendigo-Ophir Gold Project, attracting strong support from international and domestic investors.

Iress Limited reported a robust first half of 2025 with strong earnings growth and reduced leverage, driven by core business strength and strategic divestments. The company is poised to capitalize on regulatory tailwinds and technology demand in wealth and trading sectors.

JB Hi-Fi Limited reported a robust FY2025 with revenue up 10% to $10.55 billion and net profit after tax rising 5.4% to $462.4 million. The company declared a fully franked final dividend and a special dividend, while announcing a CEO succession plan.

Noxopharm Limited has successfully completed the second dose cohort in its HERACLES Phase 1 trial for SOF-SKN™, confirming safety and tolerability and moving forward to a higher dose. This progress marks a key step in developing a novel autoimmune disease treatment.

Charter Hall Social Infrastructure REIT has reported a statutory profit of $71 million for FY25, reversing last year’s loss, while advancing its portfolio through key acquisitions and refinancing.

Santos Limited has agreed to extend the exclusivity period with the XRG Consortium, allowing more time to finalize due diligence for a potential A$8.89 per share cash takeover. The extension keeps the door open for competing bids, maintaining shareholder options.

Global Health Limited has secured a $186,748 contract to implement its MasterCare+ digital platform at Jarrah House, enhancing alcohol and other drug (AOD) services with tailored technology solutions.

Yari Minerals has integrated new data from three recently drilled coal seam gas wells, revealing thicker coal seams near its Rolleston South Coal Project. This promising development could expand the project's existing 151 Mt Inferred Resource.